LL-37 (Cathelicidin)
Neutral, BioHarmony verdict
BioHarmony score 4.6 out of 10
LL-37 (Cathelicidin) is the only human cathelicidin antimicrobial peptide, with a rich antimicrobial and wound-healing mechanism but thin human therapy data: one small topical leg-ulcer trial of 34 people per Gronberg 2014, and a documented double-edge as a psoriasis autoantigen and cancer growth factor.
Read full reportWhat is LL-37 (Cathelicidin)?
LL-37 (Cathelicidin) is the only antimicrobial peptide the human body makes from the cathelicidin family, and that single fact explains both its appeal and its risks. It is a short, charged 37-residue helix cut from a precursor protein and switched on by vitamin D, infection, inflammation, and wounding. In one molecule it kills microbes, breaks up biofilms, mops up bacterial toxins, calls in immune cells, and helps wounds close. That breadth is real and genuinely impressive, and it is backed by a large mechanistic literature spanning antimicrobial, immune, and wound-repair biology.
From the BioHarmony report, reviewed Sep 8, 2026.
Saved on this device only.
How it is thought to work
Pore-forming membrane disruption of microbes, biofilm breakdown, LPS neutralization, immune-cell chemotaxis, wound re-epithelialization, and angiogenesis
Safety watch-outs
- Any personal or family history of psoriasis, lupus, or rheumatoid arthritis: do not use systemically
- LL-37 is a confirmed autoimmune trigger and autoantigen.
- Any active, prior, or suspected cancer: avoid
- LL-37 is a documented growth factor for several tumor types.
- A new or worsening skin flare, rash, or scaly plaque after starting: stop immediately, since this can reflect the psoriasis-linked…
Full risk profile in the BioHarmony report.
Dosing as published
Source-reported figures only. This page does not calculate a personal dose.
No approved-label or study protocol is recorded for LL-37 (Cathelicidin) yet.
More reported protocols
MembersMembers can compare additional reported doses, schedules, and preparation notes.
Educator coverage (2)
Attributed viewpoints, separate from primary research.
- LL-37 Enhance Your Immune System With This Amazing Peptide Hunter Williams,
- LL-37 Peptide: Benefits, Dosage and Side Effects Jay Campbell,
Trust & sourcing
- Last revieweddone
- Next reviewupcoming
FDA identifies immunogenicity and impurity concerns for compounded LL-37 and says it lacks enough safety information to determine whether it would cause harm in humans.
Primary sources
- Certain bulk drug substances for use in compounding that may present significant safety risks U.S. Food and Drug Administration,
Related peptides for recovery & tissue repair
- 7.4Thymosin Alpha-1Thymosin Alpha-1 is a 28-amino-acid thymic peptide with strongest evidence in immune-compromised and hospital-adjacent settings: Cao 2024 pooled 39 acute COPD…
- 7.2GHK-Cu (Copper Peptide)GHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5%…
- 7.1SemaxSemax is a Russian-developed ACTH 4-7 + PGP heptapeptide with the strongest human signal in post-stroke recovery, including a 110-patient Gusev et al.
- 6.9Thymosin Beta-4 (Full)Thymosin beta-4 is the native 43-amino-acid peptide that promotes tissue repair via actin-sequestering and the Ac-SDKP repair axis.
The Ultimate Peptides Guide
Spot stronger candidates, weak evidence, and seller red flags before you buy.